1. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively
   Zewei Tu et al, 2022, Frontiers in Immunology CrossRef
2. ERp57/PDIA3: new insight
   Silvia Chichiarelli et al, 2022, Cellular & Molecular Biology Letters CrossRef
3. Roles of Rictor alterations in gastrointestinal tumors (Review)
   Ruizhen Cao et al, 2024, Oncology Reports CrossRef
4. Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?
   Giuliano Paglia et al, 2023, International Journal of Molecular Sciences CrossRef